- Record: found
- Abstract: not found
- Article: not found
Bezafibrate for an inborn mitochondrial beta-oxidation defect.
2009-02-19
Adult, Bezafibrate, therapeutic use, Carnitine O-Palmitoyltransferase, deficiency, metabolism, Genes, Recessive, Humans, Hypolipidemic Agents, Lipid Metabolism, Inborn Errors, drug therapy, Mitochondrial Diseases, Oxidation-Reduction, Palmitoylcarnitine, Pilot Projects, Quality of Life, RNA, Messenger, Rhabdomyolysis, prevention & control, Statistics, Nonparametric
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Author and article information
Adult,Bezafibrate,therapeutic use,Carnitine O-Palmitoyltransferase,deficiency,metabolism,Genes, Recessive,Humans,Hypolipidemic Agents,Lipid Metabolism, Inborn Errors,drug therapy,Mitochondrial Diseases,Oxidation-Reduction,Palmitoylcarnitine,Pilot Projects,Quality of Life,RNA, Messenger,Rhabdomyolysis,prevention & control,Statistics, Nonparametric
Adult, Bezafibrate, therapeutic use, Carnitine O-Palmitoyltransferase, deficiency, metabolism, Genes, Recessive, Humans, Hypolipidemic Agents, Lipid Metabolism, Inborn Errors, drug therapy, Mitochondrial Diseases, Oxidation-Reduction, Palmitoylcarnitine, Pilot Projects, Quality of Life, RNA, Messenger, Rhabdomyolysis, prevention & control, Statistics, Nonparametric